Although generically labeled as a "recurring" form of headache, medical research concludes that a migraine headache is a genetic neurological disorder. Migraines are a painfully severe form of headache that afflicts millions of people around the world including children, with women accounting for a significant number of sufferers among them. In the US alone, an estimated 30 million people endure the disabling effects of migraine headaches and find temporary relief with medicine specially formulated to lessen the discomfort of migraine sufferers.
Credit: Divine Caroline
The search for a cure is on
While normal headaches, like common colds, both are tolerable and curable with mild medication and treatment. Current neurological research findings reveal that a migraine headache is a potentially "chronic and progressive disease"-controllable with a variety of pain-killing drugs and other medication, but not curable, as of now.
Medical researchers are working round the clock to analyze migraine headache causes and symptoms, and more importantly, to produce an effective drug to fight this debilitating disease. Medication and treatment to cure migraine headaches has still not seen the light of day.
Currently, Mayo Clinic researchers, based in Minnesota, Florida and Arizona are taking a closer look at "Telcagepant," a promising new migraine-specific drug. An international study, reported by British medical journal Lancet, has found this new drug to be highly effective in providing relief to migraine sufferers with fewer side effects than the current and widely used "Triptan" medication. The study concluded that Telcagepant had far lower adverse side effects associated with Triptan medication, such as dizziness, hot flushes, insomnia, fatigue, nausea, and dry mouth, among others.
The strongest El Nino in 50 years will unfold this winter and significantly alter the chances for a white Christmas across the country.Read Story >